Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedApr 26, 2025
DataAggregated Company Financials
Companies211
  • 7D2.7%
  • 3M-3.7%
  • 1Y3.5%
  • YTD1.5%

Over the last 7 days, the market has risen 2.7%, driven by gains of 3.7% in the Healthcare sector. As for the past 12 months, the market is up 3.5%. As for the next few years, earnings are expected to grow by 11% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 26 Apr 2025CHF 1.8tCHF 836.4bCHF 157.2b19x11.2x2.1x
Mon, 24 Mar 2025CHF 1.9tCHF 850.3bCHF 158.9b20x12.1x2.3x
Wed, 19 Feb 2025CHF 1.9tCHF 821.0bCHF 116.2b21.9x16.5x2.3x
Fri, 17 Jan 2025CHF 1.8tCHF 818.5bCHF 117.9b20.7x15.2x2.2x
Sun, 15 Dec 2024CHF 1.7tCHF 813.1bCHF 117.3b20.7x14.9x2.1x
Tue, 12 Nov 2024CHF 1.8tCHF 814.2bCHF 117.5b19.9x15.1x2.2x
Thu, 10 Oct 2024CHF 1.8tCHF 804.8bCHF 114.2b21.3x15.9x2.3x
Sat, 07 Sep 2024CHF 1.8tCHF 800.3bCHF 113.7b21.1x15.7x2.2x
Mon, 05 Aug 2024CHF 1.8tCHF 799.0bCHF 135.9b21.7x13.1x2.2x
Wed, 03 Jul 2024CHF 1.8tCHF 803.5bCHF 126.0b21.1x14.3x2.2x
Fri, 31 May 2024CHF 1.8tCHF 804.1bCHF 126.0b22.1x14.2x2.2x
Sun, 28 Apr 2024CHF 1.7tCHF 800.6bCHF 126.0b21.3x13.7x2.1x
Tue, 26 Mar 2024CHF 1.8tCHF 766.4bCHF 98.2b21.5x18x2.3x
Thu, 22 Feb 2024CHF 1.7tCHF 768.6bCHF 109.5b20.1x15.8x2.3x
Sat, 20 Jan 2024CHF 1.7tCHF 766.5bCHF 110.4b18x15.1x2.2x
Mon, 18 Dec 2023CHF 1.7tCHF 767.5bCHF 110.6b18.7x15.3x2.2x
Wed, 15 Nov 2023CHF 1.6tCHF 773.9bCHF 111.6b17.7x14.5x2.1x
Fri, 13 Oct 2023CHF 1.6tCHF 763.5bCHF 100.7b18.3x16.4x2.2x
Sun, 10 Sep 2023CHF 1.7tCHF 749.8bCHF 99.4b18.8x16.7x2.2x
Tue, 08 Aug 2023CHF 1.7tCHF 742.3bCHF 75.3b18.5x22.4x2.3x
Thu, 06 Jul 2023CHF 1.7tCHF 758.0bCHF 77.0b19.1x22.2x2.3x
Sat, 03 Jun 2023CHF 1.8tCHF 788.0bCHF 82.8b18.8x21.2x2.2x
Mon, 01 May 2023CHF 1.8tCHF 786.0bCHF 80.9b19.1x21.8x2.2x
Wed, 29 Mar 2023CHF 1.7tCHF 781.4bCHF 69.1b19.6x24.5x2.2x
Fri, 24 Feb 2023CHF 1.7tCHF 781.7bCHF 70.6b18.8x24.6x2.2x
Sun, 22 Jan 2023CHF 1.8tCHF 785.0bCHF 93.6b17.6x18.9x2.3x
Tue, 20 Dec 2022CHF 1.7tCHF 788.3bCHF 94.1b17.2x17.8x2.1x
Thu, 17 Nov 2022CHF 1.7tCHF 790.1bCHF 95.2b17.6x17.9x2.2x
Sat, 15 Oct 2022CHF 1.6tCHF 801.9bCHF 103.8b16.5x15.5x2x
Mon, 12 Sep 2022CHF 1.7tCHF 790.2bCHF 102.1b18x16.7x2.2x
Wed, 10 Aug 2022CHF 1.8tCHF 809.9bCHF 102.0b17.5x17.2x2.2x
Fri, 08 Jul 2022CHF 1.7tCHF 803.7bCHF 106.0b17x16.3x2.1x
Sun, 05 Jun 2022CHF 1.8tCHF 804.0bCHF 105.6b18.2x17.1x2.2x
Tue, 03 May 2022CHF 1.9tCHF 803.7bCHF 106.4b18x17.7x2.3x
Price to Earnings Ratio

17.7x


Total Market Cap: CHF 1.9tTotal Earnings: CHF 106.4bTotal Revenue: CHF 803.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 17.1x202320242025
Current Market PE
  • Investors are pessimistic on the Swiss market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 11.2x which is lower than its 3-year average PE of 17.1x.
Past Earnings Growth
  • The earnings for Swiss listed companies have grown 14% per year over the last three years, while revenues have remained steady.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market2.67%
Consumer Discretionary6.80%
Tech5.06%
Materials4.21%
Healthcare3.67%
Industrials3.30%
Financials2.99%
Utilities1.13%
Telecom0.77%
Real Estate0.31%
Consumer Staples-2.26%
Sector PE
  • Investors favour the Consumer Discretionary sector the most for future growth, which is trading above its 3-year average PE ratio of 23.8x.
    • Analysts expect its future annual earnings growth (13.6%) to be largely in line with prior year's earnings growth.
    • The market's confidence could indicate that the market believes that analysts are underestimating future growth.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 19% over the next 5 years.
  • However this is lower than its past earnings growth rate of 35% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 4.4% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
CFR Compagnie Financière RichemontCHF 146.507.0%
+CHF 5.7b
12.8%PE27.1xConsumer Discretionary
ROG Roche HoldingCHF 261.902.5%
+CHF 5.0b
18.5%PE25.2xHealthcare
NOVN NovartisCHF 92.542.1%
+CHF 3.6b
3.4%PE17.8xHealthcare
GALD Galderma GroupCHF 93.2518.7%
+CHF 3.5b
39.6%PE115.8xHealthcare
UBSG UBS GroupCHF 24.797.8%
+CHF 2.7b
-1.1%PE18xFinancials
See more
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Market Insights

The term ‘ Fiscal Dominance ’ has been popping up more in recent years, thanks to rising U.S. deficits. For the sake of your portfolio, this trend and its consequences are worth knowing about.

Latest News

CFR

CHF 146.50

Compagnie Financière Richemont

7D

7.0%

1Y

12.8%

BALN

CHF 184.20

Baloise Holding

7D

-0.8%

1Y

28.9%

UBSG

CHF 24.79

UBS Group

7D

7.8%

1Y

-1.1%

ABBN

CHF 43.25

ABB

7D

2.5%

1Y

-3.8%

LLBN

CHF 75.10

Liechtensteinische Landesbank

7D

-2.3%

1Y

7.6%

GALD

CHF 93.25

Galderma Group

7D

18.7%

1Y

39.6%

VONN

CHF 57.30

Vontobel Holding

7D

-2.6%

1Y

11.5%

ROG

CHF 261.90

Roche Holding

7D

2.5%

1Y

18.5%

NOVN

CHF 92.54

Novartis

7D

2.1%

1Y

3.4%

TKBP

CHF 139.50

Thurgauer Kantonalbank

7D

-3.8%

1Y

8.1%

BLKB

CHF 880.00

Basellandschaftliche Kantonalbank

7D

-2.9%

1Y

0.5%